Fluence and BioLumic join forces to equip cultivation facilities worldwide with state-of-the-art UV light treatments
This collaborative initiative between two of the world's leading companies in photobiology and agricultural technology will enable BioLumic's scientific advancements to be integrated into Fluence's award-winning lighting portfolio
AUSTIN, Texas–(BUSINESS WIRE)–Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, announced today its exclusive partnership with BioLumic, a plant-growth biotechnology company that harnesses the power of ultraviolet (UV) light to sustainably increase plant yields, health, and quality through Light Signal Recipes™. Under this agreement, Fluence and BioLumic will collaborate to deliver BioLumic’s cutting-edge UV Light Signals through Fluence’s industry-leading LED lighting solutions.
BioLumic’s patented technology harnesses UV photomorphogenesis to trigger biological reactions in seeds and seedlings, thereby significantly optimizing plant performance. The company’s proven UV Light Signal Recipes™ can lead to significant increases in crop yield, help achieve desired traits and vigor in plants, and activate their natural resistance to diseases and pests.
«At Fluence, our goal is to advance cutting-edge plant science and innovations in agricultural technologies,» said David Cohen, CEO of Fluence. «We are thrilled to pursue this goal in collaboration with BioLumic and to create the next generation of cutting-edge lighting solutions for cannabis and other crop growers around the world.»
BioLumic’s dynamic UV light treatments will be integrated into Fluence’s lighting systems for the vegetative phase of plant production; these targeted treatments will trigger benefits that accumulate throughout the plants’ growth cycle. Combining the best solutions on the market—from BioLumic and Fluence—will enable growers to achieve high-quality yield gains, increase cannabinoid levels, and improve the overall quality of the plants, while reducing variability from one cycle to the next.
«Thanks to BioLumic’s Light Signal Recipes™, growers will be able to fully and consistently harness UV lighting to improve plant growth and gene expression without incurring significant costs for inputs or chemicals,» said Steve Sibulkin, CEO of BioLumic. «This partnership will accelerate the development of BioLumic’s Light Signal Platform, expand our company’s access to the global horticulture market, and strengthen Fluence’s horticultural lighting portfolio. This is a tremendous win for growers seeking new ways to grow more with less.»
This partnership builds on Fluence’s long history of scientific innovation in the field of photobiology and follows several product launches this year, including RAPTR, the RAZR Modular System, VYNE, SPYDR Fang, SPYDR 2h, and Wireless Flex Dimming. Fluence’s dynamic and growing suite of grow lights and lighting controllers provides growers with advanced lighting technology that enables them to meet—and even exceed—their cultivation goals.
Fluence and BioLumic will initially work with selected cannabis cultivation partners while scaling up commercial UV light distribution systems, which will enhance Fluence’s end-to-end product offering in 2023. To learn more about BioLumic, visit www.biolumic.com. To learn more about Fluence, visit www.fluence.science.
About Fluence
Fluence Bioengineering, Inc. (Fluence) develops powerful, energy-efficient LED lighting solutions for commercial crop production and research applications. As a leading provider of LED lighting in the global cannabis market, Fluence is committed to enabling more efficient crop production for top growers worldwide, whether in vertical farms or greenhouses. Fluence’s global headquarters is located in Austin, Texas, and the company also has a headquarters for the EMEA region in Rotterdam, the Netherlands. Fluence operates as a business unit within Signify’s Digital Solutions division. To learn more about Fluence, visit www.fluence.science.
About BioLumic
BioLumic is an agricultural biotechnology company that uses light to “program” plants to enhance their growth, quality, and disease resistance. The company’s Light Signal Recipe™ platform combines biological information and knowledge of genetic markers to regulate gene expression through a unique application of light signals. These treatments are scalable and require no chemical applications, no genetic modification, no facility expansion, and no significant input costs. To date, BioLumic has worked with twelve crop types, including cannabis, soybeans, corn, leafy greens, and strawberries. In the cannabis sector, the company has helped growers achieve significant double-digit gains in terms of dry flower yield, THC concentration, minor cannabinoids, and terpene expression. To learn more, visit www.biolumic.com, or send an email to [email protected].
The text of the press release resulting from a translation must in no way be considered as official. The only authentic version of the press release is the one in its original language. The translation must always be compared with the source text, which will be the legal precedent.
Contact
For Fluence,
Nichole Hazard
[email protected]
Cell: 512-960-7656
For BioLumic,
Trace Stevens
[email protected]
-
Business2 weeks ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France4 weeks ago
Which countries legalized medical cannabis before France?
-
Business4 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in France4 days ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Cannabis in Thailand4 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis in the U.S.5 days ago
A DEA report confirms that there are no fatal cannabis overdoses
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in France3 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts


